Switzerland· 49456298

Clexane

A enoxaparin product containing enoxaparinum natricum, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC B01AB05

Checked against BAG Spezialitätenliste (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHBAG Spezialitätenliste (Switzerland)normalisedClexaneATCB01AB05REGISTER NO.49456298PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Enoxaparin is registered in 16 of 19 countries.

Countries holding a registration under ATC B01AB05 (enoxaparin), each read from that country’s own register.

  • This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
  • 9 of them publish a price we can compare per daily dose

Enoxaparin · ATC B01AB05

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

BAG Spezialitätenliste (Switzerland)
Active substance
enoxaparinum natricum
Manufacturer
—
Country
Switzerland (CH)
ATC code
B01AB05
ATC class
Enoxaparin
Defined daily dose
2 TSD, E
Swissmedic category
B
Reimbursed
Yes
Source register
BAG Spezialitätenliste (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680494562982
    10 Fertspr 0.8 ml
    CHF 102.5

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

203 interactions on record for enoxaparin.

Graded by severity as the source publishes them — 106 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Enoxaparin · interactions on record

203 records

  • 106 severe
  • 73 moderate

Most severe, free to view

  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • HeparinB01AB01severe
  • Antithrombin IIIB01AB02severe

24 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/84d0703c-47f2-4be9-9718-b0099af2e26a
GET /v1/drugs/84d0703c-47f2-4be9-9718-b0099af2e26a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "enoxaparinum natricum 120 mg",
  "valid_from": "2006-06-01",
  "limitations": null,
  "galenic_form": "Inj Lös 120 mg/0.8ml",
  "therapeutic_area": null,
  "sl_inclusion_date": "2006-06-01",
  "self_retention_pct": 10
}

See everything about enoxaparin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.